vaniprevir: Clinical Trials

4 trials of vaniprevir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Terminated 1

Follow vaniprevir: new trials by email Literature Review of vaniprevir trials Research Report on vaniprevir

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)
Vaniprevir 600 mg, Peg-IFN alfa-2b, Ribavirin - Chronic Hepatitis C
Phase 1CompletedMerck Sharp & Dohme LLC312012-10-302022-08-26
Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)
Vaniprevir - Chronic Hepatitis C Infection
Phase 1TerminatedMerck Sharp & Dohme LLC32010-01-132018-10-18
A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005)
Vaniprevir 300 mg, Vaniprevir 200 mg - Hepatitis C
Phase 1CompletedMerck Sharp & Dohme LLC602009-07-012018-10-09
Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED)
Comparator: MK7009, Comparator: Placebo - Hepatitis C
Phase 1CompletedMerck Sharp & Dohme LLC402007-07-012015-08-25

Conditions studied

Hepatitis C (3)  ·  Hepatitis C, Chronic (1)

Sponsors

Merck Sharp & Dohme LLC (4)

Results publications

PMID 23747481, PMID 31868916

NIH funding

2009 (1)